✦ LIBER ✦

Concomitant use of divalproex sodium and lamotrigine in developmentally disabled patients with epilepsy: a retrospective evaluation of efficacy and tolerability

✍ Scribed by Rama Maganti; Barry E Gidal; Roland Shaw; Paul Rutecki

Book ID: 117793342
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 90 KB
Volume: 3
Category: Article
ISSN: 1525-5050
DOI: 10.1016/s1525-5050(02)00028-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of lamotrigine in institutional

Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation

✍ Barry E Gidal; Jill Kerrick Walker; Rex S Lott; Ron Shaw; James Speth; Kathryn J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 93 KB

The efficacy and tolerability of divalpr

The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances

✍ Mark E. Kunik; Lucy Puryear; Claudia A. Orengo; Victor Molinari; Richard H. Work 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Behavioral disturbances are commonly encountered in elderly demented patients. The records of all patients admitted to a geropsychiatric inpatient unit within a 2-year period who had a primary diagnosis of dementia and an accompanying behavioral disturbance treated with divalproex sodium were review

Efficacy and tolerability of conversion

Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy

✍ Toufic A. Fakhoury; Anne E. Hammer; Alain Vuong; John A. Messenheimer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 237 KB

A multicentre, double-blind, randomized,

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy

✍ T Betts; T Waegemans; P Crawford 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

A 6-Month, Open-Label, Multicenter Clini

A 6-Month, Open-Label, Multicenter Clinical Study in Korean De Novo Renal Transplant Patients Evaluating the Efficacy, Safety, and Tolerance of Myfortic Concomitantly Used with Tacrolimus

✍ M.K. Ju; S.H. Park; S.J. Kim; I.S. Moon; Y.S. Kim 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 183 KB